Company profile

EnsoData, Inc.

EnsoData, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on June 16, 2021 and the most recent on June 16, 2021 (EnsoSleep). Its most common review panel is Neurology (1 device).

1AI devices
2021First decision
2021Latest decision
1Specialties

Timeline

  1. EnsoSleep · Neurology · OLZ